ALTERED LIPID PROFILE IN HYPOTHYROIDISM: A BIOCHEMICAL VIEWPOINT
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i7.24277Keywords:
Hypothyroidism, Lipid profile, Cardiovascular disease, LipoproteinsAbstract
Context: Overt hypothyroidism is the most common endocrine disorder associated with a decrease in 3,5,3'-triiodothyronine and 3,5,3',5'-tetraiodothyronine levels and increase in thyroid-stimulating hormone (TSH) levels. Thyroid hormones (THs) regulate all major metabolic pathways. THs play an important role in the synthesis, metabolism, and transport of lipids. Thyroid failure is associated with various biochemical and molecular alterations. Hypothyroidism is the common cause of secondary dyslipidemia as well as cardiovascular risk.
Objective: The present review focuses on alterations in lipid metabolism associated with hypothyroidism leading to cardiovascular risk.
Methods: The data source is from PUBMED, Google Scholar, and EMBASE. The study is a part of our previous research in studying the variations in lipid profile and transaminases in overt hypothyroidism.
Result: The serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apo B), lipoprotein (a) (Lp[a]), and triglycerides are elevated in individuals with overt hypothyroidism. In addition, it was also observed that the endothelial dysfunction, normal/depressed systolic function, left ventricular diastolic dysfunction at rest, as well as systolic and diastolic dysfunction on effort was observed in hypothyroidism.
Conclusion: THs play an important role in the regulation of lipid metabolism. Hypothyroidism is also linked with altered hemodynamics. The atherogenic lipid profile along with other predisposing factors may contribute to the coronary artery disease.
Downloads
References
Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
Almandoz JP, Gharib H. Hypothyroidism: Etiology, diagnosis, and management. Med Clin North Am 2012;96:203-21.
Pearce EN. Hypothyroidism and dyslipidemia: Modern concepts and approaches. Curr Cardiol Rep 2004;6:451-6.
Salvatore D, Davies TF, Schlumberger M, Hay ID, Larsen PR. In: Melmed S, Polonsky KS, Larsen PR, Henry MK, editors. Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders. Philadelphia, PA: Williams Text Book Of Endocrinology; 2011. p. 327-361.
Inada M, Kasagi K, Kurata S, Kazama Y, Takayama H, Torizuka K, et al. Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J Clin Invest 1975;55:1337-48.
Salvatore D, Davies TF, Schlumberger MJ, Hay ID, Larsen PR. In: Melmed S, Polonsky KS, Larsen PR, Henry MK, editors. Thyroid Physiology and Diagnostic Evaluation of Patient with Thyroid Disorders. William’s Text Book Of Endocrinology. 12th ed. Philadelphia, PA: Saunders; 2011. p. 334-415.
Mebis L, van den Berghe G. The hypothalamus-pituitary–thyroid axis in critical illness. Neth J Med 2009;67:332-40.
Duntas LH. Thyroid disease and lipids. Thyroid 2002;12:287-93.
Friis T, Pederson LR. Serum lipids in hyper and hypothyroidism before and after treatment. Clin Chim Acta 1987;162:155-63.
Tsimihodimos V, Bairaktari E, Tzallas C, Miltiadus G, Liberopoulos E, Elisaf M. The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. Thyroid 1999;9:365-8.
Chait A, Brunzel JD. Acquired hyperlipidemia (Secondary dyslipoproteinemias). Endocrinol Metab Clin North Am 1990;19:259-78.
Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am 1994;78:117-41.
Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 2012;96:269-81.
Gotto AM Jr. Interrelationship of triglycerides with lipoproteins and high–density lipoproteins. Am J Cardiol 1990;66:20A-3.
Moon JH, Kim HJ, Kim HM, Choi SH, Lim S, Park YJ, et al. Decreased expression of hepatic low-density lipoprotein receptor–related protein 1 in hypothyroidism: A novel mechanism of atherogenic dyslipidemia in hypothyroidism. Thyroid 2013;23:1057-65.
Harvey RA, Ferrier DR. Cholesterol and steroid metabolism. Unit 3-lipid metabolism. In: Lippincott’s Illustrated Reviews. Biochemistry. 5th ed. Philadelphia, PA: JB. Lippincott Company; 2011. p. 219-44.
Ohashi R, Mu H, Wang X, Yao Q, Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005;98:845-56.
Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 2007;41:401-27.
Párraga A, Bellsolell L, Ferré-D’Amaré AR, Burley SK. Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution. Structure 1998;6:661-72.
Adams CM, Goldstein JL, Brown MS. Cholesterol-induced conformational change in SCAP enhanced by insig proteins and mimicked by cationic amphiphiles. Proc Natl Acad Sci U S A 2003;100:10647-52.
Sun LP, Li L, Goldstein JL, Brown MS. Insig required for sterol-mediated inhibition of scap/SREBP binding to COPII proteins in vitro. J Biol Chem 2005;280:26483-90.
Brown MS, Goldstein JL. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997;89:331-40.
Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 1999;96:11041-8.
Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 2004;86:839-48.
Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem 2003;278:34114-8.
Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. J Clin Endocrinol Metab 2012;97:326-33.
Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: Focus on lipids and new emerging risk factors. What is the evidence? Thyroid 2007;17:1075-84.
Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones (Athens) 2002;1:218-23.
Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J 2011;5:76-84.
Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 2000;24 Suppl 2:S109-12.
Jha PK, Mandal GK. Study of thyroid profile in geriatric Type-2 diabetics in Jharkhand. Asian J Pharm Clin Res 2017;10:422-4.
Santamarina-Fojo S, González-Navarro H, Freeman L, Wagner E, Nong Z. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 2004;24:1750-4.
Al-Tonsi AA, Abdel-Gayoum AA, Saad M. The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. Exp Mol Pathol 2004;76:182-7.
Teixeira Pde F, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res 2008;151:224-31.
Pearce EN, Wilson PW, Yang Q, Vasan RS, Braverman LE. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab 2008;93:888-94.
de Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW, et al. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121-6.
Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 2000;10:803-8.
Gupta G, Sharma P, Kumar P, Sharma R. Cardiovascular risk in patients with mild to severe subclinical hypothyroidism. Asian J Pharm Clin Res 2016;9:183-5.
Bhimte B, Agrawal BK, Sharma VK, Chau SS. Oxidative stress status in hypothyroid patients. Biomed Res 2012;23:286-8.
Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116:1725-35.
Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US national health and nutrition examination survey. Atherosclerosis 2001;155:195-200.
Souad L, Cherfa A, Dalila N. The effects of homocysteine on plasma biochemical parameters and aortic matrix metalloproteinases activities. Int J Pharm Pharm Sci 2015;7:459-62.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
